Genesis Expanded Respiratory Panel
The Genesis Expanded Respiratory Panel uses polymerase chain reaction (PCR) technology to serve as a frontline diagnostic test, quickly informing the healthcare provider of Influenza, RSV, Mycoplasmas, Legionella pneumophila, and many others. The Genesis Expanded Respiratory Panel delivers the rapid, targeted clinical results that drive the most accurate diagnoses and therapies for patients. Multiplexed respiratory panel results have been shown to significantly reduce ICU days1 and the duration of antibiotic use2. Additionally, the increased certainty of viral diagnoses also ensures adherence to current antibiotic stewardship directives, reducing the likelihood of antibiotic resistance and patient morbidity3. The Genesis Expanded Respiratory Panel optimizes patient management with clinically actionable results and measurably improves patient outcomes.